Andrew D'Silva
Stock Analyst at B. Riley Securities
(3.17)
# 1,136
Out of 4,711 analysts
28
Total ratings
61.54%
Success rate
91.04%
Average return
Main Sectors:
Stocks Rated by Andrew D'Silva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OTRK Ontrak | Downgrades: Neutral | $1,350 | $1.44 | +93,650.00% | 2 | Aug 20, 2021 | |
| MPLN MultiPlan | Initiates: Buy | $400 | $6.02 | +6,544.52% | 1 | Apr 7, 2021 | |
| CYRX Cryoport | Maintains: Buy | $69 → $81 | $7.86 | +930.53% | 4 | Feb 10, 2021 | |
| GERN Geron | Maintains: Buy | $3.5 → $4 | $3.49 | +14.61% | 3 | May 29, 2020 | |
| CRMD CorMedix | Maintains: Buy | $10 → $12 | $8.57 | +40.02% | 3 | May 12, 2020 | |
| OPRX OptimizeRx | Maintains: Buy | $18 → $22 | $4.91 | +348.07% | 4 | May 5, 2020 | |
| EDAP EDAP TMS | Initiates: Buy | $5.5 | $2.19 | +151.14% | 1 | Apr 15, 2020 | |
| HROW Harrow | Maintains: Buy | $12 → $10 | $34.22 | -70.78% | 2 | Apr 7, 2020 | |
| EYPT EyePoint Pharmaceuticals | Downgrades: Neutral | $40 → $10 | $7.10 | +40.85% | 1 | Apr 6, 2020 | |
| CPIX Cumberland Pharmaceuticals | Maintains: Buy | $9 → $9.75 | $2.27 | +329.52% | 4 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $93 | $175.07 | -47.16% | 2 | Aug 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $2.37 | +743.88% | 1 | Dec 11, 2017 |
Ontrak
Aug 20, 2021
Downgrades: Neutral
Price Target: $1,350
Current: $1.44
Upside: +93,650.00%
MultiPlan
Apr 7, 2021
Initiates: Buy
Price Target: $400
Current: $6.02
Upside: +6,544.52%
Cryoport
Feb 10, 2021
Maintains: Buy
Price Target: $69 → $81
Current: $7.86
Upside: +930.53%
Geron
May 29, 2020
Maintains: Buy
Price Target: $3.5 → $4
Current: $3.49
Upside: +14.61%
CorMedix
May 12, 2020
Maintains: Buy
Price Target: $10 → $12
Current: $8.57
Upside: +40.02%
OptimizeRx
May 5, 2020
Maintains: Buy
Price Target: $18 → $22
Current: $4.91
Upside: +348.07%
EDAP TMS
Apr 15, 2020
Initiates: Buy
Price Target: $5.5
Current: $2.19
Upside: +151.14%
Harrow
Apr 7, 2020
Maintains: Buy
Price Target: $12 → $10
Current: $34.22
Upside: -70.78%
EyePoint Pharmaceuticals
Apr 6, 2020
Downgrades: Neutral
Price Target: $40 → $10
Current: $7.10
Upside: +40.85%
Cumberland Pharmaceuticals
Dec 3, 2019
Maintains: Buy
Price Target: $9 → $9.75
Current: $2.27
Upside: +329.52%
Aug 24, 2018
Maintains: Buy
Price Target: $81 → $93
Current: $175.07
Upside: -47.16%
Dec 11, 2017
Reinstates: Buy
Price Target: $20
Current: $2.37
Upside: +743.88%